1. Home
  2. AGMB vs NVEC Comparison

AGMB vs NVEC Comparison

Compare AGMB & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

HOLD

Current Price

$9.23

Market Cap

576.2M

Sector

Health Care

ML Signal

HOLD

Logo NVE Corporation

NVEC

NVE Corporation

BUY

Current Price

$68.17

Market Cap

533.1M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
AGMB
NVEC
Founded
2017
1989
Country
Belgium
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
576.2M
533.1M
IPO Year
2024
1995

Fundamental Metrics

Financial Performance
Metric
AGMB
NVEC
Price
$9.23
$68.17
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $37.67
N/A
AVG Volume (30 Days)
★ 114.4K
71.0K
Earning Date
11-14-2026
10-21-2026
Dividend Yield
N/A
★ 3.88%
EPS Growth
N/A
★ 0.96
EPS
N/A
★ 1.97
Revenue
N/A
★ $26,331,218.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$51.92
Revenue Growth
N/A
★ 1.76
52 Week Low
$7.92
$57.21
52 Week High
$17.82
$135.00

Technical Indicators

Market Signals
Indicator
AGMB
NVEC
Relative Strength Index (RSI) 42.95 19.61
Support Level $8.88 $64.40
Resistance Level $9.65 $70.63
Average True Range (ATR) 0.63 4.64
MACD 0.16 -3.26
Stochastic Oscillator 73.99 2.89

Price Performance

Historical Comparison
AGMB
NVEC

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

About NVEC NVE Corporation

NVE Corp is engaged in developing and selling devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: